Interestingly, CHCHD2 is co-amplified with EGFR in non-small cell lung carcinoma (NSCLC), and knockdown of CHCHD2 in NSCLC not only reduces cell migration but also cell proliferation and mitochondrial respiration (Wei et al., 2015). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.